bao qin gui - Net Worth and Insider Trading
bao qin gui Net Worth
The estimated net worth of bao qin gui is at least $553,800 dollars as of 2024-11-13. bao qin gui is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 20,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $553,800. Details can be seen in bao qin gui's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that bao qin gui has not made any transactions after 2022-09-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of bao qin gui
bao qin gui Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, bao qin gui owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .
Click here to see the complete history of bao qin gui’s form 4 insider trades.
Insider Ownership Summary of bao qin gui
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-22 | senior management |
bao qin gui Latest Holdings Summary
bao qin gui currently owns a total of 1 stock. bao qin gui owns 20,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 22, 2022, with a value of $553,800.
Latest Holdings of bao qin gui
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2022-09-22 | 20,000 | 27.69 | 553,800 |
Holding Weightings of bao qin gui
bao qin gui Form 4 Trading Tracker
According to the SEC Form 4 filings, bao qin gui has made a total of 2 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 10,000 shares on September 22, 2022, which cost bao qin gui around $192,400.
Insider Trading History of bao qin gui
- 1
bao qin gui Trading Performance
GuruFocus tracks the stock performance after each of bao qin gui's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by bao qin gui is 19.83%. GuruFocus also compares bao qin gui's trading performance to market benchmark return within the same time period. The performance of stocks bought by bao qin gui within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how bao qin gui's insider trading performs compared to the benchmark.
Performance of bao qin gui
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.61 | | | | | |
| Relative Return to S&P 500(%) | 4.43 | | | | | |
bao qin gui Ownership Network
Ownership Network List of bao qin gui
Ownership Network Relation of bao qin gui
bao qin gui Owned Company Details
What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?
Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?
bao qin gui is the senior management of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include Directors & senior managers wen de yong , senior management Mei Jing Ping , and senior management li sheng li .
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary
Over the past 18 months, bao qin gui made no insider transaction in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196). Other recent insider transactions involving Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) include a net sale of 0 shares made by Wang Ke Xin , a net sale of 0 shares made by wen de yong , and a net sale of 0 shares made by Guan Xiao Hui .
In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
bao qin gui Mailing Address
Above is the net worth, insider trading, and ownership report for bao qin gui. Currently GuruFocus does not have mailing address information for bao qin gui.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
